In Brief
- The endocannabinoid system (ECS) is the body’s largest regulatory network, and the skin runs its own complete version of it.
- It reaches past the skin into the fascia, where cannabinoid receptors and the cells that make hyaluronan respond directly to cannabinoids.
- A single molecule like CBD cannot meaningfully activate this network; a broad spectrum of rare cannabinoids, delivered in oil, is designed to.
- This is a current, science-grounded approach to skin and connective-tissue health, not a future promise.
The Surface Is Only Half the Story
Almost everything sold as skincare works at the surface. Retinol speeds the shedding of cells. Hyaluronic acid sits on top of the skin and holds water. Vitamin C donates an electron. Each does one thing to one layer. None of them speak to the system that actually decides how skin behaves: how quickly it renews, how fiercely it inflames, how well it holds moisture, and how resiliently it repairs.
That system is the endocannabinoid system, or ECS, the body’s master regulator of balance.4 Activating it with rare phytocannabinoids does not patch a single symptom; it supports the underlying machinery of healthy tissue, from cell-cycle control and inflammation to collagen, hydration, and barrier integrity. And, as the science now makes clear, that machinery does not stop at the skin. It runs all the way down into the fascia, the connective architecture that gives skin its firmness, contour, and bounce.19
This understanding was a long time coming, and not by accident. Medicinal hemp was removed from the U.S. Pharmacopeia in 1942, and federal cultivation was only reinstated in 2019, a near-century gap during which the ECS’s role in skin and tissue homeostasis went largely unexplored. Our work begins from the other side of that gap. Drawing on four years of research and development, including the creation of a pioneering beauty facial serum, and on the established science of the ECS, our broad-spectrum, oil-based formulations are built to engage the system where it lives: in the skin, and in the tissue beneath it. While our wider line extends to additional topicals, suppositories, and sublinguals, this document focuses on the topical story. What follows is the science behind it.
A Regulatory System Unlike Any Other
The endocannabinoid system is not one system among many. By reach, it is the largest signalling network the body has.
First characterised in the late 1980s and often called the body’s “master neuromodulator,” the ECS exists to maintain homeostasis, or balance, across an astonishing range of functions: inflammation, pain, immune response, mood, memory, repair, and more.2 Its principal receptor, CB1, is the single most abundant G-protein-coupled receptor in the human brain, and cannabinoid receptors appear in virtually every tissue and organ, including the skin and the fascia.34 No other regulatory network is so widely distributed, nor so directly responsible for keeping so many systems in balance at once.
The Most Abundant Receptors
CB1 is the most abundant G-protein-coupled receptor in the brain, and cannabinoid receptors are among the most widespread of any in the body.
Body-Wide Presence
ECS receptors are found in the skin, fascia, immune system, nervous system, gut, bone, muscle, and fat, a footprint no other system rivals.
On-Demand & Self-Limiting
Endocannabinoids are produced only where and when they are needed, then rapidly broken down: precise regulation, not blunt, constant signalling.
A True Master Regulator
Rather than driving one function, the ECS continuously tunes inflammation, repair, hydration, and barrier balance toward equilibrium.
Lipid-Native By Design
The system runs on fat-derived messengers, which is why an oil-based delivery vehicle is uniquely suited to support it.
How It Actually Works
The ECS has three working parts: the messengers, the receptors they bind, and the enzymes that switch the signal off. Together they form a continuous feedback loop that restores equilibrium whenever stress, injury, or the environment disturbs it. In the skin, that means modulating barrier function, sebum production, neuroimmune responses, and repair, the systems behind hydration, defence, and the management of inflammation.4
2-AG
The Messengers
Anandamide and 2-AG, the body’s own cannabinoids, are made on demand from membrane fats, bind their receptors to restore balance, then are quickly cleared.1
Mood, Nerves & Skin
Concentrated in the nervous system but also present in the skin, CB1 helps regulate sensation and inflammatory tone, and influences keratinocyte growth and sebocyte activity.9
Immunity & Repair
Found in immune cells, keratinocytes, fibroblasts, and the fasciacytes of connective tissue, CB2 governs inflammation and wound healing, the key target in topical care.19
MAGL
The Off-Switch
These enzymes degrade the body’s endocannabinoids once their work is done, preventing prolonged activation and keeping the signal precise.
When the System Runs Low
When the body’s production or regulation of endocannabinoids falters, a state researchers call Clinical Endocannabinoid Deficiency, the consequences surface across many systems at once: heightened inflammation, hypersensitivity, immune dysregulation, and slower repair.5 In the skin, low endocannabinoid tone has been associated with conditions marked by disrupted barrier function and neuroimmune imbalance. Modern life appears to deplete it: genetic variation affecting ECS enzymes and receptors, chronic stress, persistent inflammation, diets low in the essential fatty acids the system is built from, sedentary routines, environmental toxins and pollution, and insufficient sleep. The near-total removal of dietary phytocannabinoids over the last century may have compounded the effect. Restoring that tone is precisely what targeted phytocannabinoid support is designed to do.
Your Skin Runs Its Own Endocannabinoid System
The ECS is not something we borrow from the brain when we apply a topical. The skin operates its own, complete endocannabinoid network. Researchers have called it the “c(ut)annabinoid” system: every major skin cell type makes endocannabinoids, carries the receptors to respond to them, and uses them to keep itself in balance.4 This is why phytocannabinoids have somewhere to act the moment they reach the skin.
Sebaceous Glands
The oil glands are ECS-controlled. Cannabidiol acts as a sebostatic, calming excess oil and inflammation in sebocytes. It is one of the clearest mechanisms behind cannabinoids and clearer, less blemish-prone skin.26
Hair Follicles
The follicle is exquisitely sensitive to endocannabinoid tone, which helps govern the growth cycle, a target for both hair health and unwanted-growth concerns.4
Keratinocytes
The barrier-forming cells use ECS signalling to balance proliferation against differentiation, the rhythm behind smooth, intact, well-renewed skin.9
Immune & Pigment Cells
Resident immune cells and melanocytes carry cannabinoid receptors too, linking the ECS to inflammation, sensitivity, and pigmentation.18
In other words, ECS-targeted skincare is not introducing a foreign mechanism. It is speaking the skin’s own native language, supporting a regulatory system the skin already runs for itself.
Why CBD Alone Cannot Activate the ECS
The modern hemp and CBD market has been built almost entirely around a single molecule, cannabidiol, most often sold as an isolate, or included at levels too low to be biologically meaningful. This is a fundamental mismatch with how the ECS actually works. CBD has only weak affinity for the CB1 and CB2 receptors. Rather than activating them, it behaves as a negative allosteric modulator, subtly changing the shape of a receptor without switching the system on.67
The result is a category of products that gesture toward the endocannabinoid system without truly engaging it: isolates that forfeit the synergy of the whole plant, and minor cannabinoids added at insignificant levels for the label rather than the effect. The science points the other way, toward the entourage effect, in which multiple cannabinoids acting together produce results greater than any isolate can.8
Our formulations are built on that premise. By combining a spectrum of rare cannabinoids, chosen for more direct receptor engagement and formulated at meaningful levels, they are designed to activate the ECS rather than merely brush against it. That is the core distinction between our topicals and the isolate-based products that dominate the shelf.
Why We Leave THC Out
A spectrum of cannabinoids does not require the one that intoxicates. Our formulations are deliberately THC-free, a choice that serves both safety and reach.
Psychoactive Avoidance
THC is the primary psychoactive compound in cannabis, responsible for euphoria and for unwanted side effects. Leaving it out makes our products suitable for confident daily use, including by those with sensitive skin or professional obligations, with no psychoactive effect and no drug-test risk.
Regulatory Compliance
THC restrictions vary worldwide. By excluding it, our formulations align with FDA guidance for hemp-derived products containing less than 0.3% THC, avoid legal friction across jurisdictions, and remain suitable for broad international distribution.
The Fascia: Where Skin Is Anchored
Skin is usually treated as two layers. It is, in truth, the visible surface of a single, continuous connective-tissue system that runs inward through the fascia.
And the fascia is not a bystander to the endocannabinoid system. Research has established that it carries the very same receptors our formulations are designed to engage, making the connective scaffolding beneath the skin an active participant in ECS signalling, not merely a neighbour to it.1921
What the Fascia Is
Moving inward from the surface, the body is layered: epidermis, dermis, then the superficial fascia within the hypodermis, the deep or muscular fascia, a plane of loose connective tissue, and finally muscle. The superficial fascia separates skin from the musculoskeletal system and lets the two glide independently, the quality that gives skin its mobility, suppleness, and youthful resilience. Far from inert packing, fascia is a dynamic, sensory, richly cellular tissue of fibroblasts, collagen, elastin, and a hydrated ground substance.
Fasciacytes & the Body’s Own Hyaluronan
The fascia contains a specialised cell, the fasciacyte, whose dedicated job is to produce hyaluronan, the same hyaluronic acid sold in serums.22 The hyaluronan fasciacytes secrete fills the spaces between tissues, dampens mechanical tension, and lubricates the planes between fascial layers so everything glides. When these cells falter, the layers begin to stick, glide is lost, and tissue feels stiff, tethered, and aged.23
This reframes one of skincare’s most familiar ingredients. Topical hyaluronic acid is the finished molecule, laid on the surface for a temporary effect. The fascia is the body’s own, internally regulated source of it. Supporting the cells that manufacture hyaluronan addresses hydration and glide at their origin, not as a coating, but as a capacity.
The Receptors Run Deeper Than the Dermis
Research has shown that fascial fibroblasts express both CB1 and CB2 receptors, and that the wider endocannabinoid system is present throughout fibroblasts and myofascial tissue.1921 The fascia, in other words, is wired into the same signalling network as the skin and the nervous system. The receptor machinery our formulations engage at the surface is also present in the connective tissue directly beneath it.
Cannabinoids & Matrix Remodelling
Exposing human fascial cells to a cannabinoid triggered the rapid production of hyaluronan, within hours, alongside remodelling of the surrounding matrix. ECS engagement can prompt the tissue to make and organise its own hyaluronan: a regenerative model, not a cosmetic one.20
The literature is careful here: the two receptors can pull in different directions. CB2 activation is consistently anti-inflammatory and anti-fibrotic, while CB1, in some settings, can promote fibrosis. This is part of why a balanced, multi-cannabinoid approach aimed at restoring healthy tone, rather than blunt, single-receptor stimulation, is the more sensible goal.25
The Body’s Richest Sensory Organ
Fascia is not passive wrapping. It is the most densely innervated tissue we have. The fascial network is estimated to contain on the order of 250 million nerve endings, rivalling the skin itself, with nociceptors and proprioceptors woven through it.28 Because the same endocannabinoid receptors sit within this richly sensory tissue, researchers have proposed that the endocannabinoid system may help modulate fascial inflammation and discomfort, which is part of why cannabinoids are now being studied in the context of myofascial comfort.192029
Densification, Not Just Scarring
There is an important and hopeful distinction in fascial science. Fibrosis is true scarring: disorganised collagen, hard to reverse. Densification is different: a change in the viscosity of the hyaluronan-rich layer that makes fascia stiff and sticky and costs it its glide, and it is considered readily reversible when hyaluronan is restored.29 Much of what reads on the surface as stiff, dull, “aged” tissue is densification, not permanent damage, precisely the state a system that renews the fascia’s own hyaluronan is positioned to address.
A Newly-Mapped Space
In 2018, researchers formally described the interstitium, a continuous, fluid-filled, collagen-supported space running through the fascia and connective tissues throughout the body, large enough that some have called it an overlooked organ.30 It is a reminder of how recently this terrain has been mapped, and how much of skin and tissue health lives in the connective layers conventional skincare has never addressed.
Why It Shows on the Surface
How skin looks (its firmness, contour, smoothness, and freedom from dimpling) depends heavily on the connective architecture beneath it. The superficial fascia organises subcutaneous fat and anchors the skin, and the fibrous strands running through it are directly implicated in the dimpled look of cellulite. Well-hydrated, freely gliding, low-inflammation fascia reads at the surface as taut, mobile, resilient skin; stiff, dehydrated, fibrotic fascia reads as laxity and crepiness. By supporting fascial hydration and matrix balance through the ECS, topical phytocannabinoids may influence skin appearance at a structural level surface actives simply cannot reach.
Inflammaging and the System That Fades With It
Two of the clearest drivers of skin ageing are a slow, smouldering inflammation and a regulatory system that quietly winds down with the years.
Scientists call the first inflammaging: a chronic, low-grade inflammation that builds with age as cells become senescent and leak inflammatory signals into the tissue around them. In the skin, this background inflammation is now recognised as a central driver of lines, laxity, and dullness, not merely a side effect of getting older.31
The second is the ECS itself. Endocannabinoid tone declines with age: CB1 receptor density falls substantially across a lifespan and anandamide levels drop, so the very system that keeps inflammation in check becomes less able to do so, just when it is needed most.32 This is the core case for ECS-targeted care: rather than chasing the visible signs, it supports the regulatory tone that fades with age and lets inflammation take hold. Addressing the driver, not only the surface.
Why Oil: The Delivery Problem
An active is only as good as its ability to reach its target. Cannabinoids are strongly lipophilic, fat-loving, with oil-water partition values around 6–7 and almost no water solubility.34 That single property dictates how they must be delivered.
The skin’s barrier is built from lipids, and the most viable route for a fat-soluble molecule is the intercellular lipid matrix between cells, with the sebaceous-follicle route as a second path inward.34 A water-based cream asks a fat-loving molecule to travel through a medium it resists; an oil-based vehicle works with the skin’s own chemistry, carrying cannabinoids into the lipid-rich layers where the ECS, in the dermis and the fascia below, actually lives. The delivery system is not a detail. For this class of molecule, it is half the mechanism.
The Rare Cannabinoids We Use
Where most products rely on a single molecule, our broad-spectrum, THC-free formulations bring together a spectrum of rare cannabinoids so they can work in concert, the entourage effect.8 Each contributes a distinct action in skin and connective tissue; together they cover far more of the ECS than any isolate can.111217
Cannabidiol
Calms inflammation and supports barrier repair; modulates TRPV1 and PPAR-γ to soothe reactive skin.16
Cannabigerol
Anti-inflammatory and antibacterial; in studies, reduces oxidative stress in fibroblasts and targets collagen and elastin genes.12
Cannabidiolic Acid
A potent calming acid precursor that helps settle flare-ups, with high receptor affinity.
Cannabigerolic Acid
Helps regulate inflammation and oxidative stress via the ECS and MAPK pathway, and supports DNA repair.11
Cannabichromene
Anti-inflammatory; shown to inhibit Th2 cytokines and JAK/STAT signalling in atopic-dermatitis models, and supports regeneration.14
Cannabinol
Supports cell-cycle balance and repair; shows TRPV1-mediated anti-inflammatory activity in keratinocytes and synergy with CBD.15
Cannabidivarin
Helps reduce inflammation and oxidative stress and supports barrier stabilisation.
Cannabicyclol
Adds antimicrobial synergy and helps support compromised, reactive skin.
Cannabicitran
Associated with supporting orderly cell division and genomic integrity within the blend.
Regulation, Not Just Correction
Scientific research positions the ECS as a master regulator of skin homeostasis, influencing inflammation, barrier function, and cellular renewal.4 Conventional skincare is built on single-action ingredients that address a symptom without engaging that system. Our oil-based, multi-cannabinoid formulations are designed to do the opposite, to work with the ECS across both skin and fascia. Because the body operates as a lipid-based system within its tissues, oil-based delivery also integrates more seamlessly with the skin’s natural lipid matrix than water-based creams. Set side by side, the contrast is clear.
vs. Our Approach
Accelerates turnover but can irritate and raise photosensitivity. We support renewal with anti-inflammatory action, and no photosensitivity.
vs. Our Approach
Topical hyaluronic acid hydrates briefly at the surface. We engage the fasciacytes that make the body’s own hyaluronan, with deeper lipid-based delivery.
vs. Our Approach
A potent antioxidant, but unstable and quick to oxidise. We offer stable, broad-spectrum antioxidant action plus anti-inflammatory and regenerative support, and cannabinoids such as CBG have been shown to work alongside stabilised vitamin C in UV-stressed skin cells.1213
vs. Our Approach
Signal collagen with limited absorption and no regulatory reach. We support collagen through ECS pathways while modulating inflammation and repair.
Direct head-to-head clinical comparisons remain limited; these distinctions are drawn from mechanistic research on ECS modulation.
What Our Topical Agents Deliver
Firmness & Radiance
CBDA and CBGA help support the skin’s youthful-looking firmness, while CBD and CBG help defend against oxidative stress, for visibly improved texture, clarity, and elasticity, and a calmer, more even-looking complexion.
Skin & the Tissue Beneath
Formulated to engage the endocannabinoid system not only in the skin but in the fascia, the connective tissue beneath it, helping skin look and feel supple, cushioned, and resilient rather than tight or tired.
Calm & Comfortable Feel
Helps reactive, sensitive skin look and feel calm and comfortable, soothing the appearance of redness and supporting a balanced complexion against everyday environmental stress.
Suppleness & Glide
By supporting the supple, gliding quality of healthy skin and the connective layers beneath, the formulations help skin feel mobile and cushioned, not stiff or dull.
Whole-System Balance
Designed to work with the body’s own regulatory system rather than override it, supporting a calm, balanced, healthy-looking complexion that reflects overall well-being.
Why It Stands Apart
Beyond what each cannabinoid does in the skin, the approach itself is built to be broad, safe, and durable, a set of advantages no single-action ingredient can claim.
Holistic, Targeted Health
Addresses inflammation, ageing, and blemishes together through multi-cannabinoid synergy, rather than one symptom at a time.
Enhanced Efficacy
The entourage effect lets combined cannabinoids amplify one another beyond what any isolate achieves.
Natural, Not Synthetic
Plant-based and suitable for all skin types, aligned with clean-beauty values over synthetic retinoids or peptides.
Gentle & Tolerated
Irritant-free and well suited to sensitive skin, avoiding common allergens found in conventional formulations.
Ethical & Sustainable
Cruelty-free and responsibly sourced, meeting the expectations of conscious consumers.
Globally Compliant
THC-free by design, ensuring legal accessibility and broad international distribution.
The Whole Picture
A dysregulated ECS, worsened by stress, pollution, diet, and sleep deficits, impairs the body’s ability to maintain balance across both the skin and its connective tissue.
Our phytocannabinoid formulations are designed to help restore that balance: soothing inflammation, supporting the cellular machinery of renewal, and engaging the fascia where the body produces its own hyaluronan and organises its structural matrix. By acting on the master regulatory system rather than on surface symptoms alone, they aim to compensate for deficiency and support optimal function from the visible surface to the connective foundation beneath it, a holistic approach that conventional, single-target ingredients are not built to deliver.
What We Make, and Why It Is Different
Reset ECS develops broad-spectrum, THC-free, oil-based topical formulations, including our pioneering facial serum and a complementary line of topical products, created specifically to support and engage the endocannabinoid system at the level of the skin and the connective tissue beneath it. Each is built around a spectrum of rare cannabinoids, formulated to harness the entourage effect, and delivered in a lipid base intended to integrate with the skin’s own matrix.
In contrast to the isolate-based or under-dosed products that define much of the category, our formulations are designed to engage the ECS directly rather than nominally. That difference (a true spectrum of cannabinoids, at meaningful levels, delivered in oil) is the whole point.
These are cosmetic formulations intended to support the appearance, comfort, and supple feel of healthy skin and the connective tissue beneath it. They are not intended to diagnose, treat, cure, or prevent any disease.
The Science, in More Depth
Everything so far stands on its own. What follows is the deeper molecular detail, written for practitioners and anyone who wants to see the mechanisms up close.
Three layers of evidence sit beneath the story above: the wider network of receptors cannabinoids engage in the skin, the master signalling pathways they influence, and how they help keep cell renewal in balance. None of it is required reading to understand the approach, but all of it is what the approach is built on.
The Receptor Orchestra
CB1 and CB2 are only the beginning. Phytocannabinoids speak to a whole orchestra of receptors in the skin, which is precisely why a single molecule can never do the job.
Much of the market talks as though the ECS were just CB1 and CB2. In the skin, cannabinoids also engage the TRP channels (TRPV1–4 and TRPA1) that govern heat, sensation, itch, barrier formation, and oil production; the PPAR nuclear receptors that steer inflammation and how skin cells mature; and signalling receptors such as GPR55 and 5-HT1A.2733 Different cannabinoids prefer different members of this orchestra, so a blend reaches targets no isolate can.
The Switches the ECS Controls
Through its broad receptor network, the ECS interfaces with several of the master pathways that govern how skin behaves, the deeper control circuits that determine renewal, pigmentation, regeneration, and the response to stress. Rare phytocannabinoids can nudge these circuits toward balance in ways surface ingredients never touch.1118
Growth & Proliferation
Overactive mTOR drives the excessive cell turnover seen in thickened, inflamed skin and in psoriasis. ECS activation can temper it, helping rebalance cellular metabolism and curb hyperplasia.10
ERK
Renewal & Photo-Ageing
Governing maturation, pigmentation, and the UV response, this pathway is modulated by rare cannabinoids such as CBG and CBC to support anti-inflammatory and anti-photo-ageing effects.119
Regeneration & Repair
Essential for stem-cell maintenance, wound healing, and follicle cycling, this pathway is supported via CB2, with cannabinoids implicated in countering fibrosis and scarring.25
AKT
Survival & Resilience
Regulating cell survival and the response to oxidative stress, this pathway helps preserve fibroblast function and vascular integrity in ageing skin.16
The Cell Cycle, Kept in Balance
Healthy skin depends on the orderly progression of the cell cycle: G1 (growth), S (DNA synthesis), G2 (preparation), and M (division), the process behind repair, growth, and maintenance. By influencing the regulatory proteins and checkpoints that govern each stage, ECS modulation supports renewal while guarding against runaway proliferation, so the result is renewal that is regulated rather than merely accelerated.10
Growth
As the cell grows and prepares to replicate, CBD and CBG help modulate cyclins and CDKs, inducing arrest where needed; the acid precursors CBDA and CBGA add receptor affinity.
DNA Synthesis
During replication, rare cannabinoids may support repair mechanisms and reduce oxidative damage, CBDV in particular, helping preserve genomic fidelity.
Preparation
Before mitosis, CBN may help upregulate tumour-suppressor proteins such as p53 at the G2/M checkpoint, while CBC supports DNA-repair gene expression.
Division
During division itself, CBT and CBL may influence mitotic-spindle formation and chromosomal segregation, supporting accurate, healthy division.
The Regulators Behind the Phases
Cyclins and CDKs drive the cycle forward; CBD and CBG can downregulate them to support controlled turnover. Tumour suppressors such as p53 and Rb act as the brakes, with CBGA and CBDA binding effectively to promote the clearance of damaged cells. Proto-oncogenes, when mis-signalled, push proliferation; CBDV and CBC help modulate those pathways. At the checkpoints, G1/S and G2/M, cannabinoids such as CBGA, CBG, CBN, and CBD help ensure only healthy cells advance, while spindle-assembly stability guards against the chromosomal errors (aneuploidy) that accompany disordered division.